These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Bressler NM; Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980 [TBL] [Abstract][Full Text] [Related]
6. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC; Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study. Sharp DM; Lai S; Markey CM Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991 [TBL] [Abstract][Full Text] [Related]
9. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients]. Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900 [TBL] [Abstract][Full Text] [Related]
10. Acute severe vision decrease immediately after photodynamic therapy. Beaumont P; Lim CS; Chang A; Kang K Arch Ophthalmol; 2004 Oct; 122(10):1546-7. PubMed ID: 15477472 [No Abstract] [Full Text] [Related]
11. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients. Bessler NM; Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071 [TBL] [Abstract][Full Text] [Related]
12. Large submacular hemorrhages after verteporfin therapy. Do DV; Bressler NM; Bressler SB Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883 [TBL] [Abstract][Full Text] [Related]
13. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. Isola V; Pece A; Parodi MB Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867 [TBL] [Abstract][Full Text] [Related]
15. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. Frennesson CI; Nilsson SE Acta Ophthalmol Scand; 2004 Dec; 82(6):645-50. PubMed ID: 15606458 [TBL] [Abstract][Full Text] [Related]
16. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features. Keane PA; Aghaian E; Ouyang Y; Chong LP; Sadda SR Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S85-8. PubMed ID: 21117609 [TBL] [Abstract][Full Text] [Related]
17. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209 [TBL] [Abstract][Full Text] [Related]
18. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Isola V; Pece A; Brancato R Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088 [No Abstract] [Full Text] [Related]
19. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Barbazetto I; Burdan A; Bressler NM; Bressler SB; Haynes L; Kapetanios AD; Lukas J; Olsen K; Potter M; Reaves A; Rosenfeld P; Schachat AP; Strong HA; Wenkstern A; ; Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608 [TBL] [Abstract][Full Text] [Related]
20. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]